Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.
2.
4.
5.

Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.

Sandberg M, Hammerschmidt W, Sugden B.

J Virol. 1997 Jun;71(6):4649-56.

6.

CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines.

Pokrovskaja K, Ehlin-Henriksson B, Kiss C, Challa A, Gordon J, Gogolak P, Klein G, Szekely L.

Int J Cancer. 2002 Jun 10;99(5):705-12.

8.
9.

LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3.

Wu S, Xie P, Welsh K, Li C, Ni CZ, Zhu X, Reed JC, Satterthwait AC, Bishop GA, Ely KR.

J Biol Chem. 2005 Sep 30;280(39):33620-6. Epub 2005 Jul 11.

10.

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.

Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS.

Oncogene. 1997 Jun 19;14(24):2899-916.

11.
12.

High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.

Pullen SS, Labadia ME, Ingraham RH, McWhirter SM, Everdeen DS, Alber T, Crute JJ, Kehry MR.

Biochemistry. 1999 Aug 3;38(31):10168-77.

PMID:
10433725
13.
14.

Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes.

Xie P, Hostager BS, Bishop GA.

J Exp Med. 2004 Mar 1;199(5):661-71. Epub 2004 Feb 23.

16.
17.

Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs.

Brodeur SR, Cheng G, Baltimore D, Thorley-Lawson DA.

J Biol Chem. 1997 Aug 8;272(32):19777-84.

18.

Signaling and protein associations of a cell permeable CD40 complex in B cells.

Zoog SJ, Papov VV, Pullen SS, Jakes S, Kehry MR.

Mol Immunol. 2004 Jan;40(10):681-94.

PMID:
14644094
20.

TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1.

Ardila-Osorio H, Pioche-Durieu C, Puvion-Dutilleul F, Clausse B, Wiels J, Miller W, Raab-Traub N, Busson P.

Int J Cancer. 2005 Jan 10;113(2):267-75.

Supplemental Content

Support Center